BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37584415)

  • 21. [Advances of Cas9/sgRNA delivery system for gene editing].
    Hu X; Wang S; Yu L; Zhang X; Chen W
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3880-3889. PubMed ID: 34841792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulus-Responsive Smart Nanoparticles-Based CRISPR-Cas Delivery for Therapeutic Genome Editing.
    Naeem M; Hoque MZ; Ovais M; Basheer C; Ahmad I
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A quaternary ammonium-based nanosystem enables delivery of CRISPR/Cas9 for cancer therapy.
    Zhang M; Sun S; Liang X; Liu Z; Yin J; Li Q; Yang S
    Biomater Sci; 2024 Feb; 12(5):1197-1210. PubMed ID: 38240497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing.
    Xiu K; Saunders L; Wen L; Ruan J; Dong R; Song J; Yang D; Zhang J; Xu J; Chen YE; Ma PX
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing.
    Fang T; Cao X; Ibnat M; Chen G
    J Nanobiotechnology; 2022 Aug; 20(1):354. PubMed ID: 35918694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progresses of CRISPR/Cas9 genome editing in forage crops.
    Ul Haq SI; Zheng D; Feng N; Jiang X; Qiao F; He JS; Qiu QS
    J Plant Physiol; 2022 Dec; 279():153860. PubMed ID: 36371870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
    Hu X; Meng X; Liu Q; Li J; Wang K
    Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
    Liu C; Zhang L; Liu H; Cheng K
    J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Cas9 Based Genome Editing in Wheat.
    Smedley MA; Hayta S; Clarke M; Harwood WA
    Curr Protoc; 2021 Mar; 1(3):e65. PubMed ID: 33687760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A RecET-assisted CRISPR-Cas9 genome editing in Corynebacterium glutamicum.
    Wang B; Hu Q; Zhang Y; Shi R; Chai X; Liu Z; Shang X; Zhang Y; Wen T
    Microb Cell Fact; 2018 Apr; 17(1):63. PubMed ID: 29685154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boosting targeted genome editing using the hei-tag.
    Thumberger T; Tavhelidse-Suck T; Gutierrez-Triana JA; Cornean A; Medert R; Welz B; Freichel M; Wittbrodt J
    Elife; 2022 Mar; 11():. PubMed ID: 35333175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery of CRISPR/Cas9 for therapeutic genome editing.
    Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
    J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Versatile Redox-Responsive Polyplexes for the Delivery of Plasmid DNA, Messenger RNA, and CRISPR-Cas9 Genome-Editing Machinery.
    Wang Y; Ma B; Abdeen AA; Chen G; Xie R; Saha K; Gong S
    ACS Appl Mater Interfaces; 2018 Sep; 10(38):31915-31927. PubMed ID: 30222305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes.
    Jain PK; Lo JH; Rananaware S; Downing M; Panda A; Tai M; Raghavan S; Fleming HE; Bhatia SN
    Nanoscale; 2019 Nov; 11(44):21317-21323. PubMed ID: 31670340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vivo Genome Editing in Type I and II Methanotrophs Using a CRISPR/Cas9 System.
    Rumah BL; Claxton Stevens BH; Yeboah JE; Stead CE; Harding EL; Minton NP; Zhang Y
    ACS Synth Biol; 2023 Feb; 12(2):544-554. PubMed ID: 36688528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A DNA Origami-Based Gene Editing System for Efficient Gene Therapy in Vivo.
    Tang W; Tong T; Wang H; Lu X; Yang C; Wu Y; Wang Y; Liu J; Ding B
    Angew Chem Int Ed Engl; 2023 Dec; 62(51):e202315093. PubMed ID: 37906116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in genome editing of bloodstream forms of Trypanosoma congolense using CRISPR-Cas9 ribonucleoproteins: Proof of concept.
    Minet C; Chantal I; Berthier D
    Exp Parasitol; 2023 Sep; 252():108589. PubMed ID: 37516291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.